Today: 13 April 2026

BILL Holdings (BILL) Surges as Company Explores a Sale — What Investors Need to Know Today (Nov. 12, 2025)

BILL Holdings (BILL) Surges as Company Explores a Sale — What Investors Need to Know Today (Nov. 12, 2025)

BILL Holdings shares jumped 13% to $52.68 after reports said the company is exploring a possible sale with help from financial advisers. Talks are in early stages, with no guarantee of a deal. The review follows activist pressure from Starboard Value, which took an 8.5% stake and prompted board changes in October. BILL has not commented on the process.
Anthropic Pledges $50 Billion for U.S. AI Data Centers in Texas and New York, With First Sites Coming Online in 2026

Anthropic Pledges $50 Billion for U.S. AI Data Centers in Texas and New York, With First Sites Coming Online in 2026

Anthropic will invest $50 billion to build AI data centers in the U.S., with initial sites in Texas and New York developed with Fluidstack and coming online through 2026. The company expects to create about 800 permanent and 2,400 construction jobs. This marks Anthropic’s first major direct data center program after mainly using cloud partners. Anthropic also plans to access up to one million Google Cloud TPUs in parallel.
FMFC Stock Jumps on Nov. 12: Kandal M Venture (NASDAQ: FMFC) Rebounds Pre‑Market After Steep Slide—No New Filings or Fresh Company News

FMFC Stock Jumps on Nov. 12: Kandal M Venture (NASDAQ: FMFC) Rebounds Pre‑Market After Steep Slide—No New Filings or Fresh Company News

Shares of Kandal M Venture (NASDAQ: FMFC) surged as much as 70% pre-market Wednesday, then traded up 29% at $0.72 by 14:55 UTC on volume over 15.6 million shares. No new SEC filings or press releases were issued. The stock had collapsed from above $15 in October to below $1 in early November. FMFC went public in June at $4 per share.
12 November 2025
reAlpha Tech Corp. (NASDAQ: AIRE) posts 326% Q3 revenue surge; files fresh 10‑Q & 8‑K, highlights AI mortgage tools — November 12, 2025

reAlpha Tech Corp. (NASDAQ: AIRE) posts 326% Q3 revenue surge; files fresh 10‑Q & 8‑K, highlights AI mortgage tools — November 12, 2025

reAlpha Tech Corp. reported Q3 revenue of $1.45 million, up 326% from a year earlier, but posted a net loss of about $5.8 million. Gross margin fell to 52% from 67%. The company filed its 10-Q and 8-K, listing 128 million shares outstanding as of Nov. 12. reAlpha expanded mortgage and realty operations into Georgia, Utah, and Nevada.
Dollar General (DG) News Today — Nov. 12, 2025: Upstate NY walkout, shopper‑trend headwinds, and where the stock trades now

Dollar General (DG) News Today — Nov. 12, 2025: Upstate NY walkout, shopper‑trend headwinds, and where the stock trades now

Six workers at Dollar General Store #16215 in Duanesburg, NY, staged a walkout last week over understaffing and missing sick time, local media report. Hispanic shopper visits to dollar stores fell nearly 6% year-over-year, according to new Reuters data. Dollar General shares traded near $104.88 as of 14:56 UTC. The company reports Q3 results on December 4.
12 November 2025
Clearwater Analytics (CWAN) Weighs Sale; Shares Jump as Wellington Files 6.2% Stake and New Report Flags $2.7T Insurance ‘Alts’ Shift

Clearwater Analytics (CWAN) Weighs Sale; Shares Jump as Wellington Files 6.2% Stake and New Report Flags $2.7T Insurance ‘Alts’ Shift

Clearwater Analytics shares jumped about 8.6% Wednesday after Bloomberg reported the company is weighing a potential sale following takeover interest. Wellington Management disclosed a 6.2% passive stake in a new SEC filing. Clearwater also released a study showing U.S. insurers now hold $2.7 trillion in alternative assets.
CorMedix (CRMD) Q3 2025: Net Income Hits $108.6M, FY25 Guidance Raised to $390–$410M — Nov 12, 2025

CorMedix (CRMD) Q3 2025: Net Income Hits $108.6M, FY25 Guidance Raised to $390–$410M — Nov 12, 2025

CorMedix Inc. reported Q3 2025 net revenue of $104.3 million and net income of $108.6 million, citing strong DefenCath demand and Melinta portfolio sales. The company raised full-year pro forma revenue guidance to $390–$410 million and expects $115–$135 million in Q4 net revenue. Integration of Melinta is ahead of schedule, with $30 million in synergies targeted by year-end. CorMedix is rebranding as “CorMedix Therapeutics.”
12 November 2025
Viking Holdings (VIK) pops onto Bank of America’s ‘beyond‑AI’ stock list as Q3 results near — Nov. 12, 2025

Viking Holdings (VIK) pops onto Bank of America’s ‘beyond‑AI’ stock list as Q3 results near — Nov. 12, 2025

Bank of America added Viking Holdings to its “beyond tech/AI” stock picks Wednesday, citing Viking’s dominant river cruise market share and premium itineraries. Viking is set to report Q3 results on Nov. 19, with analysts expecting around $1.19 EPS on $2.0 billion revenue. The company posted $1.88 billion revenue and $0.99 EPS last quarter. Investors will watch yield, bookings, and fleet updates.
CMCT Sells Lending Arm to Peachtree Affiliate for ~$44M; Stock Jumps, CFO Transition Set — Nov. 12, 2025

CMCT Sells Lending Arm to Peachtree Affiliate for ~$44M; Stock Jumps, CFO Transition Set — Nov. 12, 2025

Creative Media & Community Trust Corporation agreed to sell its lending division, First Western SBLC, Inc., to a Peachtree Group affiliate for about $44 million, pending SBA approval. CMCT expects roughly $31 million in net cash after debt and fees. CFO Barry Berlin will resign at closing, with Brandon Hill set to take over. Shares jumped over 70% intraday following the announcement.
Opendoor (OPEN) News Today — Nov 12, 2025: CEO Kaz Nejatian Buys $1M in Stock as Warrant Dividend Nears; Shares Hold Gains

Opendoor (OPEN) News Today — Nov 12, 2025: CEO Kaz Nejatian Buys $1M in Stock as Warrant Dividend Nears; Shares Hold Gains

Opendoor CEO Kasra Nejatian bought 125,000 shares for about $1 million on Nov. 11, according to a Form 4 filed Tuesday. The purchase comes ahead of next week’s special warrant dividend and follows a 21% stock surge Monday. As of 14:26 UTC, shares traded near $8.48. Opendoor reported Q3 revenue of $915 million and a $90 million net loss last week.
12 November 2025
BigBear.ai (BBAI) Today: Stock Moves, $250M Ask Sage Deal, and Q3 Beat — What Investors Need to Know (Nov 12, 2025)

BigBear.ai (BBAI) Today: Stock Moves, $250M Ask Sage Deal, and Q3 Beat — What Investors Need to Know (Nov 12, 2025)

BigBear.ai shares traded heavily around $6.40 pre-market after Q3 results and a $250 million deal to acquire Ask Sage. TipRanks’ AI Analyst cut the price target to $5.50 (Neutral), while broader analyst targets remain near $6–$7. Q3 revenue was $33.1 million, down 20% year-over-year. The Ask Sage deal is expected to close late Q4 2025 or early Q1 2026.
Jumia (JMIA) Q3 2025: Revenue +25%, GMV +21%, Orders Surge; FY‑2025 Loss Guided to $50–55M, Q4’26 Breakeven Target

Jumia (JMIA) Q3 2025: Revenue +25%, GMV +21%, Orders Surge; FY‑2025 Loss Guided to $50–55M, Q4’26 Breakeven Target

Jumia Technologies reported Q3 2025 revenue of $45.6 million, up 25% year over year, with adjusted EBITDA loss narrowing to $14 million from $17 million. Orders rose 34%, led by Nigeria’s GMV surge of 43%. The company refined its 2025 loss outlook to $50–55 million before tax and reaffirmed a path to profitability. Shares fell about 7% intraday despite early gains.
12 November 2025
G4 ‘Severe’ Solar Storm Today (Nov. 12, 2025): X5.1 Flare Triggers Radio Blackouts; Northern Lights Stretch From Mexico to Australia

G4 ‘Severe’ Solar Storm Today (Nov. 12, 2025): X5.1 Flare Triggers Radio Blackouts; Northern Lights Stretch From Mexico to Australia

NOAA reported G4 (Severe) geomagnetic storm levels early Nov. 12, triggered by an X5.1 solar flare from sunspot AR4274. Auroras were seen as far south as Mexico and the U.S. Gulf Coast, with the UK logging local G5 bursts and record geoelectric fields. Forecasters warn more strong storms and auroras are possible through Nov. 14 as further CMEs approach.
12 November 2025
Viking Therapeutics (VKTX) Pops as Canaccord Nudges Price Target to $107; Stifel Conference Buzz & Fresh ObesityWeek® Data — Nov. 12, 2025

Viking Therapeutics (VKTX) Pops as Canaccord Nudges Price Target to $107; Stifel Conference Buzz & Fresh ObesityWeek® Data — Nov. 12, 2025

Canaccord Genuity raised its Viking Therapeutics (VKTX) price target to $107, maintaining a Buy rating amid ongoing investor focus on obesity drug data. VKTX shares traded near $40 intraday as management appeared at the Stifel Healthcare Conference. Recent VENTURE trial results showed VK2735 led to 78% of prediabetics reaching normoglycemia, compared to 29% with placebo.
12 November 2025
Lucyd (NASDAQ: LUCY) Pops Pre‑Market as Q3 Results Are Expected Today — Rebrand, Exec Moves, and New AI Safety Glasses in Focus (Nov. 12, 2025)

Lucyd (NASDAQ: LUCY) Pops Pre‑Market as Q3 Results Are Expected Today — Rebrand, Exec Moves, and New AI Safety Glasses in Focus (Nov. 12, 2025)

Lucyd, Inc. (LUCY) jumped 23% to around $1.90 in Wednesday’s pre-market, with heavy early trading ahead of its expected Q3 earnings release. Shares spiked to $2.17 after hours Tuesday. The move follows a recent corporate rebrand, executive changes, and the launch of new ChatGPT-enabled Lucyd Armor smart-safety glasses. Pre-market volume reached over 5 million shares, compared to about 4.6 million shares outstanding.
FedEx (FDX) Jumps as Profit Outlook Brightens; New SAF at O’Hare & Miami, Japan Transit Gains — What to Know Today (Nov. 12, 2025)

FedEx (FDX) Jumps as Profit Outlook Brightens; New SAF at O’Hare & Miami, Japan Transit Gains — What to Know Today (Nov. 12, 2025)

FedEx shares rose about 5.4% intraday after management projected fiscal Q2 EPS above last year’s $4.05, calming peak-season concerns. The company began sustainable aviation fuel deliveries at Chicago O’Hare and Miami, and said most flights remain unaffected by FAA capacity limits and MD-11 inspections. Export shipments from Aichi and Gifu, Japan, now reach many Asian destinations a day faster.
12 November 2025
Salarius Pharmaceuticals (SLRX) Stock Jumps as $7M Offering Prices; Closing Expected November 12, 2025 Amid Decoy Therapeutics Merger

Salarius Pharmaceuticals (SLRX) Stock Jumps as $7M Offering Prices; Closing Expected November 12, 2025 Amid Decoy Therapeutics Merger

Salarius Pharmaceuticals priced a $7 million underwritten public offering, with closing contingent on its merger with Decoy Therapeutics. The deal includes common shares, pre-funded warrants, and fixed-price Series A and B warrants. Shares plunged up to 51% Tuesday after the financing news, then rebounded over 50% pre-market and up to 65% intraday today. The merger is expected to close around November 12, 2025.

Stock Market Today

  • Standard & Poor's Global (SPGI) October 16 Options Begin Trading with Notable Premium Opportunities
    April 13, 2026, 11:47 AM EDT. Standard and Poor's Global Inc (SPGI) saw new options start trading for the October 16th expiration, featuring 186 days until expiry. Longer time to expiration increases the time value of these contracts, offering potential for higher premiums for sellers of put and call options. The $250 strike put contract, trading at a $1.15 bid, allows sellers to potentially buy shares at an effective price of $248.85, presenting a nearly 40% discount to current prices and a 96% chance the option expires worthless. On the call side, the $430 strike call bid at $32 offers a covered call yield of 10.20% if exercised, though it caps upside gains. These new contracts provide investors various strategic choices based on market views and risk appetite.

Latest article

Salesforce Stock News: Choreo and Sumitomo Mitsui Cuts Resurface, but the Filings Are Months Old

Salesforce Stock News: Choreo and Sumitomo Mitsui Cuts Resurface, but the Filings Are Months Old

13 April 2026
Salesforce faced renewed attention after reports of stake reductions by Choreo LLC and Sumitomo Mitsui Trust Group, based on SEC filings from January that reflected year-end positions. Choreo held 27,733 shares and Sumitomo Mitsui 2,478,864 shares as of December 31. The reported cuts amounted to about 35% and 8.6%, respectively. Salesforce shares rose 3.4% Monday, while broader software stocks remain down for the year.
Sandisk Stock Jumps as Nasdaq-100 Adds AI Storage Winner, Atlassian Exits

Sandisk Stock Jumps as Nasdaq-100 Adds AI Storage Winner, Atlassian Exits

13 April 2026
Sandisk shares jumped 7.3% to $913.56 after Nasdaq said the company will join the Nasdaq-100 on April 20, replacing Atlassian. The move follows strong demand for AI-related data storage and analyst price target hikes. Atlassian exits as software stocks slump, with its shares down 65% this year. Sandisk reports fiscal third-quarter results on April 30.
Did the New York Times Really Unmask Satoshi Nakamoto? Adam Back Denies Bitcoin Founder Claim as Doubts Persist

Did the New York Times Really Unmask Satoshi Nakamoto? Adam Back Denies Bitcoin Founder Claim as Doubts Persist

13 April 2026
Adam Back, British cryptographer and Blockstream CEO, again denied being Bitcoin creator Satoshi Nakamoto after renewed media scrutiny, including a New York Times report naming him the top candidate. No hard proof has emerged. Bitcoin traded near $71,580 Monday, with Satoshi’s suspected holdings worth about $78.7 billion. Markets showed little reaction to the speculation.
CoreWeave stock jumps again after Anthropic AI deal adds to $21 billion Meta pact

CoreWeave stock jumps again after Anthropic AI deal adds to $21 billion Meta pact

13 April 2026
CoreWeave shares rose 7.5% to $109.64 on Monday after announcing a deal to supply Anthropic with AI computing capacity. The stock had already surged over 13% Friday on news of the agreement. CoreWeave also disclosed a new $21 billion order from Meta last week and priced $5.25 billion in new debt to fund expansion. Financial terms of the Anthropic contract were not disclosed.
Morgan Stanley’s Lowest-Fee Bitcoin ETF Is Just the Start as Bank Eyes Tokenization, Tax Tools

Morgan Stanley’s Lowest-Fee Bitcoin ETF Is Just the Start as Bank Eyes Tokenization, Tax Tools

13 April 2026
Morgan Stanley is considering tokenized money-market funds and digital-asset tax tools just days after launching its MSBT bitcoin ETP, which drew $61.8 million in its first three sessions. MSBT, listed on NYSE Arca, charges a 0.14% sponsor fee, the lowest among U.S. bitcoin ETPs. The bank has also filed for Bitcoin, Ethereum, and Solana trusts. Coinbase and BNY handle custody for MSBT.
Go toTop